Two COVID shots effective against India variant, English health body says
Published
The study found the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the variant two weeks after the second dose.
Full ArticlePublished
The study found the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the variant two weeks after the second dose.
Full ArticleWatch VideoLONDON — British government regulators on Friday authorized another coronavirus vaccine for use in the U.K. amid..
(MENAFN - Gulf Times) The requirement of a booster shot for the Covid-19 vaccine, within eight to 12 months after the second shot..